In this Health IT Answers article, Scott Gray, CEO, discusses modern patient-centric methods to remove barriers and increase access in rare disease clinical trials, such as prioritizing patient engagement, embracing digital solutions, and investing in supplemental patient support services.
Featured in SCRS InSite Journal: Scott Gray, CEO, discusses patient recruitment and retention, two of the most pressing challenges facing clinical research today. Continue reading to learn more about understanding the financial, logistical, and emotional barriers to participation, the consequences of poor retention and enrollment, actionable steps to improve trial outcomes, and other key findings …
Amplifying the Voice of the Patient in Rare Disease Trials Read More »
In this SCRS Talks podcast, Scott Gray, CEO, highlights statistics from an independent, IRB-approved survey of patients and caregivers regarding participation in clinical trials. Learn about the financial risks of patient dropouts and trial delays, plus practical strategies for making trial participation easier and encouraging patient retention.
Featured in Clinical Researcher: Scott Gray, CEO, discusses the business case for patient experience, including the patient’s role in clinical trial return on investment (ROI), the benefits of patient centricity, and investing in patient experience.
PharmaVoice 100 award recipient, Scott Gray, CEO, founder, and president of Clincierge is championing diversity, equity, and inclusion (DEI) within the company and beyond.
PHILADELPHIA, Sept. 6, 2022 /PRNewswire/ — Clincierge CEO Scott Gray has been named to the PharmaVoice 100, an annual list recognizing the most inspiring people in life sciences.
In this Empowered Patient Podcast with Karen Jagoda, Scott Gray, CEO, discusses how providing patient support services can improve patient recruitment, retention, and outcomes in clinical trials.
PHILADELPHIA, July 5, 2022 – Titan CEO and headline sponsor Wipfli LLP are pleased to announce the 2022 Philadelphia Titan 100. The Titan 100 program recognizes Philadelphia’s Top 100 CEO’s & C-level executives. They are the area’s most accomplished business leaders in their industry using criteria that includes demonstrating exceptional leadership, vision, and passion.
Featured in Clinical Researcher: Scott Gray, CEO discusses the importance of a hybrid approach to decentralized trials for patients with rare diseases.
Featured on CenterWatch.com: Newly published results from a survey, conducted by the patient support service company Clincierge, found that 95 percent of the trial participants responded and 98 percent of their caregivers considered it essential to have a single point of contact to help them throughout a trial, especially when arranging travel plans.
View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.
